Back
Allogene Therapeutics Stock Price Chart
Sponsored
ALLO
Sponsored
MarketBeat Alert: Strong sell signal just issued for these 20 stocks
Go here now to get free instant access to all 20 stocks to sell.
Sell
26
ALLO
Allogene Therapeutics
Last Price:
3.07
Seasonality Move:
10.59%
7 Day Trial
ALL ACCESS PASS
$
7
MarketBeat Alert: Escape the market madness with 7 stocks to buy and hold
The result is a select group of high-quality blue-chip stocks.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALLO is experiencing slight selling pressure.
Allogene Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.96 | Buy |
20-day SMA: | 3.42 | Sell |
50-day SMA: | 4.18 | Sell |
200-day SMA: | 3.68 | Sell |
8-day EMA: | 3.01 | Sell |
20-day EMA: | 3.36 | Sell |
50-day EMA: | 3.77 | Sell |
200-day EMA: | 4.19 | Sell |
Allogene Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.37 | Sell |
Relative Strength Index (14 RSI): | 30.38 | Sell |
Chaikin Money Flow: | -575172 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (3.07 - 4.09) | Sell |
Bollinger Bands (100): | (3 - 4.64) | Sell |
Allogene Therapeutics Technical Analysis
Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | May | |||||||||
19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Allogene Therapeutics Stock
Is Allogene Therapeutics Stock a Buy?
- Allogene Therapeutics share price is 2.97 while ALLO 8-day simple moving average is 2.96, which is a Buy signal.
- The stock price of ALLO is 2.97 while Allogene Therapeutics 20-day SMA is 3.42, which makes it a Sell.
- Allogene Therapeutics 50-day simple moving average is 4.18 while ALLO share price is 2.97, making it a Sell technically.
- ALLO stock price is 2.97 and Allogene Therapeutics 200-day simple moving average is 3.68, creating a Sell signal.
ALLO Technical Analysis vs Fundamental Analysis
Sell
26
Allogene Therapeutics (ALLO)
is a Sell
Is Allogene Therapeutics a Buy or a Sell?
-
Allogene Therapeutics stock is rated a Sell
The current Allogene Therapeutics [ALLO] share price is $2.97. The Score for ALLO is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
Allogene Therapeutics Stock Info
Market Cap:
502.2M
Price in USD:
2.97
Share Volume:
1.4M
Allogene Therapeutics 52-Week Range
52-Week High:
6.89
52-Week Low:
2.23
Sell
26
Allogene Therapeutics (ALLO)
is a Sell
Allogene Therapeutics Share Price Forecast
-
What is the Allogene Therapeutics stock price today?
The Allogene Therapeutics stock price is 2.97 USD today. -
Will ALLO stock go up or go down?
Allogene Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Allogene Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Allogene Therapeutics is overvalued.
Is Allogene Therapeutics Stock a Buy?
- Allogene Therapeutics share price is 2.97 while ALLO 8-day exponential moving average is 3.01, which is a Sell signal.
- The stock price of ALLO is 2.97 while Allogene Therapeutics 20-day EMA is 3.36, which makes it a Sell.
- Allogene Therapeutics 50-day exponential moving average is 3.77 while ALLO share price is 2.97, making it a Sell technically.
- ALLO stock price is 2.97 and Allogene Therapeutics 200-day simple moving average is 4.19, creating a Sell signal.
Fundamental Analysis of Allogene Therapeutics
Is Allogene Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.12 per share, a decrease next quarter of $0.02 per share, an increase this year of $0.39 per share, and a decrease next year of $0.04 per share.
Technical Analysis of Allogene Therapeutics
Should I short Allogene Therapeutics stock?
- ALLO Moving Average Covergence Divergence (MACD) indicator is -0.37, suggesting Allogene Therapeutics is a Sell
- Allogene Therapeutics Relative Strength Index (RSI) is 30.38, which suggest Allogene Therapeutics is oversold
- The Bollinger Bands (25) for Allogene Therapeutics is (3.07 - 4.09), which suggest Allogene Therapeutics is a Sell
- The Bollinger Bands (100) for Allogene Therapeutics is (3 - 4.64), which suggest Allogene Therapeutics is a Sell
* Allogene Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.